HemCon Medical Technologies, Inc. GuardIVa®Antimicrobial Hemostatic IV Dressing Obtains Additional FDA Clearance and HCPCS Reimbursement Codes  
9/4/2012 10:11:51 AM

PORTLAND, Ore.--(BUSINESS WIRE)--HemCon Medical Technologies (“HemCon”), a leading global developer of advanced medical technologies and products, announced receiving an additional U.S. regulatory clearance for the antimicrobial hemostatic IV dressing GuardIVa®, that is part of its European subsidiary product portfolio. GuardIVa® Antimicrobial Hemostatic IV Dressing is an adjunct to infection control measures by providing sustained IV site protection. The dressing is a flexible, absorptive sponge disk that can be easily placed around catheters to absorb exudate, cover and protect sites such as central venous catheters (CVC) and peripherally inserted central catheters (PICC).